In patients having cardiac surgery, prospectively refusing blood transfusions was associated with shorter hospital stays and improved short-term but not long-term survival compared with having transfusions.
Long-term mechanical circulatory support (MCS) with ventricular assist devices (VADs) is now an acceptable option for patients with end-stage heart failure (HF).
